Bill and Melinda Gates Foundation: Global Grand Challenges – Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing
Research Admin Offices:
- ROADS
- HRS
Funding Type:
GrantOpportunity Type:
- Grant
Value:
Up to $750,000 USD over 18 months.
Disciplines:
- Health Sciences
Sponsors:
Deadlines:
Internal Deadline:
May 15, 2025Sponsor Deadline:
May 31, 2025Description:
This opportunity supports innovative approaches to significantly reduce the manufacturing costs of monoclonal antibodies, making them more affordable for low- and middle-income countries.
Resources:
Contact:
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.
ROADS: For more information and to apply, contact Beatrice Fletcher, Senior Advisor.